JACC-Cardiovascular Interventions
Scope & Guideline
Pioneering Research in Cardiovascular Interventions
Introduction
Aims and Scopes
- Transcatheter Valve Interventions:
This area covers innovations and outcomes related to transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair/replacement, and tricuspid valve interventions, showcasing techniques like edge-to-edge repair and valve-in-valve procedures. - Coronary Intervention Techniques:
Research in this scope addresses the development and optimization of percutaneous coronary interventions (PCI), including the use of drug-coated balloons, stent technologies, and techniques for chronic total occlusion (CTO) recanalization. - Cardiovascular Imaging and Guidance:
This focus area emphasizes the role of imaging modalities such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and computed tomography (CT) in guiding interventional procedures and assessing outcomes. - Clinical Outcomes and Risk Assessment:
This scope includes studies on the prognostic implications of various interventions, patient selection criteria, and risk models for patients undergoing interventional procedures, particularly in high-risk groups. - Transcatheter Therapies for Structural Heart Disease:
Research on the application of transcatheter techniques for structural heart disease management, including edge-to-edge repairs and valve replacements in various anatomical and pathological contexts. - Innovative Technologies and Devices:
The journal highlights the development of novel devices and technologies, including new stent designs, delivery systems, and adjunctive therapies aimed at improving procedural safety and effectiveness.
Trending and Emerging
- Integration of Artificial Intelligence:
There is a growing interest in the application of artificial intelligence (AI) for predicting outcomes, guiding interventions, and personalizing treatment plans, indicating a technological shift in cardiology. - Minimally Invasive Techniques:
Research focusing on minimally invasive procedures, particularly in the context of transcatheter interventions, is on the rise, reflecting a broader trend towards reducing patient morbidity. - Patient Selection and Personalized Medicine:
There is an increasing emphasis on the importance of personalized medicine in interventional cardiology, with studies exploring how specific patient characteristics influence treatment outcomes. - Use of Novel Biomarkers:
Emerging research is focusing on new biomarkers for predicting patient outcomes and guiding therapy, indicating a trend towards more tailored cardiovascular interventions. - Comprehensive Assessment of Valve Disease:
An increased focus on the comprehensive assessment of valve disease, including multi-valve involvement and the integration of various treatment modalities, is becoming more prominent in recent publications.
Declining or Waning
- Conventional Surgical Techniques:
There is a noticeable decline in research focused on traditional surgical techniques for valve replacements, as the field moves towards less invasive transcatheter approaches. - Long-term Outcomes of Older Devices:
As newer technologies and devices gain prominence, studies focusing on older devices and their long-term outcomes are becoming less frequent, indicating a shift towards evaluating contemporary solutions. - Basic Cardiovascular Physiology Studies:
Research that purely focuses on basic cardiovascular physiology without direct application to interventional techniques is less frequently represented, as the emphasis shifts towards clinical applications and outcomes. - Single-Center Studies:
There seems to be a decline in single-center studies, as multicenter and larger registry studies are preferred for their robustness and generalizability. - Generic Comparisons of Antiplatelet Therapies:
Comparative studies on generic antiplatelet therapies are less common as more complex, individualized approaches to treatment emerge, prioritizing patient-specific factors.
Similar Journals
Netherlands Heart Journal
Leading the Way in Cardiovascular Research and PracticeNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
Cardiovascular Revascularization Medicine
Advancing Techniques for Heart HealthCardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.
ACTA CARDIOLOGICA
Advancing cardiovascular knowledge since 1946.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Journal fur Kardiologie
Exploring the Heart of Cardiovascular Research.The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.
Postepy w Kardiologii Interwencyjnej
Connecting scholars and practitioners to shape the future of cardiology.Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.
Korean Circulation Journal
Elevating Cardiovascular Science Through Innovative Research.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.
Heart International
Connecting researchers and clinicians in the pursuit of heart health.Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.
EuroIntervention
Empowering Healthcare Professionals with Cutting-Edge KnowledgeEuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.
Cardiology Journal
Empowering global research in cardiology.Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.
Journal of Cardiovascular Medicine
Uncovering Breakthroughs in CardiologyWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.